The Vitiligo CloudBank is a free self-help patient portal that lets you monitor your condition and treatment progression. It is anonymous, easy to use and offers you the opportunity to collate, focus and streamline your vitiligo health data, treatments and photos.
Sharing your details via the CloudBank will also make a real difference, as your contribution helps doctors and researchers who are collating information from vitiligo sufferers across the world. Understanding and analyzing this data is a vital factor in the search for a cure for vitiligo.
The CloudBank also gives you the chance to seek expert opinion on your condition, by sharing your details with doctors registered on the CloudBank. You simply need to grant temporary access to your health record, email or send a print-out of your profile to one of the many doctors listed on the site, then you will receive expert opinion on your condition and how best to treat it.
Please help us to help you and the millions of other vitiligo sufferers across the world and join the CloudBank today.
To get started with your CloudBank journey, simply click here. All you need to provide is your email address to log in, then any information you supply is completely anonymous.
If you have any questions about the vitiligo CloudBank and how to use it, please contact us.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
NY Vitiligo Community Meeting in September
Our next meeting will be on Thursday, September 21st, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Av...21 September 2017 19:00, 11th floor of NYU's Ambulatory Car...
Vitiligo Advocacy Day at the US Capitol
Save-the-Date for the much anticipated Vitiligo Advocacy Day at the United States Capitol this fall. As many of you know, the Advocacy Committee of the Global Vitilig...04 October 2017 10:00, Washington, DC
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials in relation vitiligo. Profs. Henry Lim, Mark Lebwohl and coauthors reported (PubMed) results of mult...
Who is prone to vitiligo?
Vitiligo affects 0.5-2% of the population, and occurs in all races and all social levels. Vitiligo can affect people of all ages, but often starts between the ages of ...
I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling co...
What tests should be done?
No tests are usually necessary to make the diagnosis. The white patches may be seen more easily under Wood's light examination.